Journal
NEUROSCIENCE LETTERS
Volume 491, Issue 2, Pages 148-152Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2011.01.026
Keywords
alpha-Synuclein; Reactive oxygen species; Malondialdehyde; Oxidative stress; Parkinson's disease; Rotenone
Categories
Funding
- National Natural Science Foundation of China [30973887, 81073078, 81073130, U832008, 90713045]
- Special Purpose for New Drug Development [2008ZX09101, 2009ZX09303, 2009ZX09301-003-11-1]
- Ministry of Education of China [20070023075, 20070023037]
Ask authors/readers for more resources
The alpha-synuclein protein is a major component of Lewy bodies found in the brains of patients with Parkinson's disease (PD). Recently, alpha-synuclein 98 (alpha-syn98), a small isoform of the wild type protein was isolated. The neurotoxicity of this protein was assessed by over-expressing alpha-syn98 in dopaminergic cells. Enhanced expression of alpha-syn98 was insufficient to adversely affect the survival of neurons or to promote aggregation of the protein. However, when exposed to rotenone, alpha-syn98 over-expressing dopaminergic cells demonstrated significantly increased cytotoxicity and aggregate formation. Furthermore, we found enhanced basal ROS production and MDA levels in alpha-syn98 over-expressing neurons. High basal oxidative stress induced by alpha-syn98, combined with oxidative stress caused by rotenone treatment, promoted aggregate formation and significantly decreased cell viability. These data indicate that alpha-syn98 can enhance the susceptibility of dopaminergic neurons to oxidative insults by raising steady-state levels of oxidative stress. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available